Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 3
2007 7
2008 2
2009 3
2010 5
2012 1
2013 6
2014 4
2015 6
2016 1
2017 1
2018 2
2019 2
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.
Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri M. Challagundla KB, et al. Among authors: neviani p. J Natl Cancer Inst. 2015 May 13;107(7):djv135. doi: 10.1093/jnci/djv135. Print 2015 Jul. J Natl Cancer Inst. 2015. PMID: 25972604 Free PMC article.
Genetic events other than BCR-ABL1.
Neviani P. Neviani P. Curr Hematol Malig Rep. 2014 Mar;9(1):24-32. doi: 10.1007/s11899-013-0194-x. Curr Hematol Malig Rep. 2014. PMID: 24407376 Review.
Exosomic microRNAs in the Tumor Microenvironment.
Neviani P, Fabbri M. Neviani P, et al. Front Med (Lausanne). 2015 Jul 22;2:47. doi: 10.3389/fmed.2015.00047. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26258125 Free PMC article. Review.
Protein phosphatase 2A: a target for anticancer therapy.
Perrotti D, Neviani P. Perrotti D, et al. Among authors: neviani p. Lancet Oncol. 2013 May;14(6):e229-38. doi: 10.1016/S1470-2045(12)70558-2. Lancet Oncol. 2013. PMID: 23639323 Free PMC article. Review.
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Silvestri G, Trotta R, Stramucci L, Ellis JJ, Harb JG, Neviani P, Wang S, Eisfeld AK, Walker CJ, Zhang B, Srutova K, Gambacorti-Passerini C, Pineda G, Jamieson CHM, Stagno F, Vigneri P, Nteliopoulos G, May PC, Reid AG, Garzon R, Roy DC, Moutuou MM, Guimond M, Hokland P, Deininger MW, Fitzgerald G, Harman C, Dazzi F, Milojkovic D, Apperley JF, Marcucci G, Qi J, Polakova KM, Zou Y, Fan X, Baer MR, Calabretta B, Perrotti D. Silvestri G, et al. Among authors: neviani p. Blood Cancer Discov. 2020 Jul;1(1):48-67. doi: 10.1158/0008-5472.BCD-19-0039. Blood Cancer Discov. 2020. PMID: 32974613 Free PMC article.
SETting OP449 into the PP2A-activating drug family.
Neviani P, Perrotti D. Neviani P, et al. Clin Cancer Res. 2014 Apr 15;20(8):2026-8. doi: 10.1158/1078-0432.CCR-14-0166. Epub 2014 Mar 14. Clin Cancer Res. 2014. PMID: 24634375 Free PMC article.
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Vannini I, et al. Among authors: neviani p. Nat Commun. 2018 Jan 8;9(1):160. doi: 10.1038/s41467-017-02485-1. Nat Commun. 2018. PMID: 29311577 Free PMC article.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page